Eliza Chakravarty to Risk Assessment
This is a "connection" page, showing publications Eliza Chakravarty has written about Risk Assessment.
Connection Strength
0.214
-
The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v2-v8.
Score: 0.130
-
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken). 2021 01; 73(1):146-157.
Score: 0.039
-
Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken). 2015 Mar; 67(3):313-25.
Score: 0.026
-
Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res (Hoboken). 2011 Mar; 63(3):358-65.
Score: 0.019